Nobel Biocare Holding AG (Nobel Biocare Holding AG) Enterprise Value : $2,235.1 Mil (As of May. 23, 2024)

Nobel Biocare Holding AG Enterprise Value Chart

Nobel Biocare Holding AG Annual Data
	Trend	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
Enterprise Value		Get a 7-Day Free Trial					-	2,313.07	1,434.26	968.28	1,642.17

Nobel Biocare Holding AG Semi-Annual Data
	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
Enterprise Value	Get a 7-Day Free Trial							-	2,313.07	1,434.26	968.28	1,642.17

Competitive Comparison of Nobel Biocare Holding AG's Enterprise Value

For the Medical Instruments & Supplies subindustry, Nobel Biocare Holding AG's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nobel Biocare Holding AG's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nobel Biocare Holding AG's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Nobel Biocare Holding AG's Enterprise Value falls into.

Nobel Biocare Holding AG Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Nobel Biocare Holding AG's Enterprise Value for the fiscal year that ended in Dec. 2013 is calculated as

Nobel Biocare Holding AG's Enterprise Value for the quarter that ended in Dec. 2013 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nobel Biocare Holding AG  (OTCPK:NBHGF) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Nobel Biocare Holding AG's EV-to-EBIT for today is

Nobel Biocare Holding AG's current Enterprise Value is $2,235.1 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Nobel Biocare Holding AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2013 was $87.7 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Nobel Biocare Holding AG's EV-to-EBITDA for today is:

Nobel Biocare Holding AG's current Enterprise Value is $2,235.1 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Nobel Biocare Holding AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2013 was $125.1 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Nobel Biocare Holding AG's EV-to-Revenue for today is:

Nobel Biocare Holding AG's current Enterprise Value is $2,235.1 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Nobel Biocare Holding AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2013 was $776.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nobel Biocare Holding AG Enterprise Value Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description